Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of IQVIA Holdings (NYSE:IQV) through any online brokerage.
Other companies in IQVIA Holdings’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and Illumina Inc (NASDAQ:ILMN).
IQVIA Holdings has a consensus price target of $264.26.
The stock price for IQVIA Holdings (NYSE: IQV) is $258.11 last updated October 7, 2026 at 4:27 PM EDT.
There are no upcoming dividends for IQVIA Holdings.
IQVIA Holdings does not have any upcoming earnings scheduled.
There is no upcoming split for IQVIA Holdings.
IQVIA Holdings is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NYSE.